MedPath

A study of the efficacy of preoperative chemotherapy and radiation therapy for rectal cancer

Not Applicable
Conditions
rectal cancer
Registration Number
JPRN-UMIN000018563
Lead Sponsor
Tokyo Women's Medical University Hospital
Brief Summary

The completion rate of CRT was high at 94% (n=29/31). The downstaging rate of CRT was 61% (n=19/31). The pathological complete response rate was 6.5% (n=2/31). Significant differences were observed in the 3-year local recurrence rate between the two groups (P<0.05).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Preoperative diagnosis of rectal cancer in M or MP and N0 Stage I (Japanese Classification of Colorectal Carcinoma the 7th edition) (2)Patients who principal investigator has determined to be inappropriate as a subject

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3-year local control rate
Secondary Outcome Measures
NameTimeMethod
(1)3-year over-all survival rate (2)Complete chemoradiotherapy rate (3)Postoperative complications rate
© Copyright 2025. All Rights Reserved by MedPath